Source Paper
Aberrant Hippocampal Activity Underlies the Dopamine Dysregulation in an Animal Model of Schizophrenia
Daniel J. Lodge, Anthony A. Grace
Journal of Neuroscience • 2007
View Abstract
Evidence supports a dysregulation of subcortical dopamine (DA) system function as a common etiology of psychosis; however, the factors responsible for this aberrant DA system responsivity have not been delineated. Here, we demonstrate in an animal model of schizophrenia that a pathologically enhanced drive from the ventral hippocampus (vHipp) can result in aberrant dopamine neuron signaling. Adult rats in which development was disrupted by prenatal methylazoxymethanol acetate (MAM) administration display a significantly greater number of spontaneously firing ventral tegmental DA neurons. This appears to be a consequence of excessive hippocampal activity because, in MAM-treated rats, vHipp inactivation completely reversed the elevated DA neuron population activity and also normalized the augmented amphetamine-induced locomotor behavior. These data provide a direct link between hippocampal dysfunction and the hyper-responsivity of the DA system that is believed to underlie the augmented response to amphetamine in animal models and psychosis in schizophrenia patients.
Amphetamine-Induced Locomotor Activity
Objective: Measurement of locomotor responses to amphetamine administration in MAM-treated and control rats to assess dopamine system responsivity and evaluate the relationship between hippocampal dysfunction and dopamine system hyper-responsivity
Gather these items before starting the experiment. Check off items as you prepare.
Equipment1
Not specified • Not mentioned • Not mentioned • Not mentioned
Materials2
Not specified • Not applicable • Not mentioned • Not mentioned
Not specified • Not applicable • Not mentioned • Not mentioned
Software1
Not specified • Not mentioned
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Protocol Steps
Prenatal MAM treatment
Administer methylazoxymethanol acetate prenatally to disrupt normal development and create the animal model of schizophrenia
Note: Creates MAM-treated group with altered dopamine system responsivity
View evidence from paper
“Adult rats in which development was disrupted by prenatal methylazoxymethanol acetate (MAM) administration”
Amphetamine administration and locomotor measurement
Administer amphetamine to adult MAM-treated and control rats and measure resulting locomotor activity responses
Note: MAM-treated rats display significantly greater amphetamine-induced locomotor behavior compared to controls
View evidence from paper
“normalized the augmented amphetamine-induced locomotor behavior”
Ventral hippocampus inactivation (in MAM-treated rats)
Inactivate the ventral hippocampus in MAM-treated rats to assess its role in dopamine system dysregulation
Note: Inactivation completely reversed elevated dopamine neuron population activity and normalized amphetamine-induced locomotor behavior
View evidence from paper
“vHipp inactivation completely reversed the elevated DA neuron population activity and also normalized the augmented amphetamine-induced locomotor behavior”